RXRX Recursion Pharmaceuticals Inc
Company Analysis
Latest News
🟢 Recursion Pharmaceuticals is trading 11% up today
Recursion Pharmaceuticals is trading at $4.56, up 10.61%, with no fresh company-specific announcement or clear catalyst identified for the October 5, 2026...
🟢 Recursion Pharmaceuticals is trading 4.3% up today
Recursion Pharmaceuticals is trading 4.38% up at $4.30, with no fresh company-specific announcement or clear catalyst identified for the October 5 move. -...
🟢 Recursion Pharmaceuticals is trading 4.8% up today amid broader market gains
Recursion Pharmaceuticals is trading 4.79% higher at $4.26 on October 2, 2026, with broader market strength likely contributing to the gain. - Major indices...
🟢 Recursion Pharmaceuticals is trading 4.1% up with no confirmed catalyst
Recursion Pharmaceuticals is trading at $4.20, up 4.09% as of 10:19 a.m. EDT on September 30, 2026; no fresh company-specific announcement or confirmed...
🟢 Recursion Pharmaceuticals is trading 7.7% up; catalyst remains uncertain
Recursion Pharmaceuticals is trading 7.7% up at $3.98 on September 29, 2026, with no clear company-specific announcement explaining the intraday gain. - Recent...
🔴 Recursion Pharmaceuticals is trading 4.1% down today with no clear company-specific catalyst
Recursion Pharmaceuticals is trading 4.1% down at $3.73, with no clear company-specific explanation for the decline. - No new company-specific announcement,...
🟢 Recursion Pharmaceuticals is trading 5% up today despite biotech sector weakness
Recursion Pharmaceuticals is trading at $3.89, up 5.14%, despite weakness across biotechnology stocks. - The XBI biotech ETF is down 2.04%, suggesting the...
🔴 Recursion Pharmaceuticals is trading 4.6% down today as U.S. equities weaken
Recursion Pharmaceuticals is trading 4.6% down at $3.87 as U.S. equities weaken. - The Nasdaq Composite is down 1.00%, and the S&P 500 is down 0.55%. - Brent...
🟢 Recursion Pharmaceuticals rises 4.2% — Biotech Sector Rallies on Major AI Collaboration Deal and Positive Clinical News
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is trading higher, driven by a...
🟢 Recursion Pharmaceuticals is trading 4% up today after Tempus committed $42 million in payments
Recursion Pharmaceuticals is trading at $3.98 (+4.05%) on September 21, 2026, after expanding its Tempus AI partnership and licensing its TxFM RNA sequencing...
Recursion Expands Tempus AI Partnership, Licenses AI Model for $12M Fee
Recursion Pharmaceuticals has entered into two agreements with Tempus AI, Inc., expanding their collaboration. The company amended its existing master data...
🟢 Recursion Pharmaceuticals is trading 5.37% up today amid broader biotech strength
Recursion Pharmaceuticals is trading 5.37% up now at $3.73, appearing to benefit mainly from broader biotechnology strength. - The sector is up 2.55%, while...
🟢 Recursion Pharmaceuticals is trading 10.91% up today as biotech rises 2.55%
Recursion Pharmaceuticals is trading 10.91% up at $3.54, primarily amid biotech-sector strength; no clear company-specific announcement was identified for...
🟢 Recursion Pharmaceuticals is trading 7.82% up today amid biotech-sector strength
Recursion Pharmaceuticals is trading at $3.44, up +7.82%, primarily as biotechnology gains 2.55% amid stronger pharmaceutical demand, increased research...
🔴 Recursion Pharmaceuticals is trading 5.1% down today as biotech sector weakens
Recursion Pharmaceuticals is trading at $3.23 (-5.13%) amid biotech-sector weakness. - XBI is down 2.11%, alongside broader pressure from rising Treasury...
🟢 Recursion Pharmaceuticals is trading 5% up today
Recursion Pharmaceuticals is trading at $3.36, up 5.07%, with no clear company-specific catalyst identified for the intraday gain. - Recent coverage...
🔴 Recursion Pharmaceuticals is trading 5.52% down today as U.S. equities retreat
Recursion Pharmaceuticals is trading 5.52% down at $3.25 as broad risk-off pressure weighs on U.S. equities. - The S&P 500 is down 0.45%, while the Nasdaq...
🔴 Recursion Pharmaceuticals is trading 5.37% down today amid broader risk-off trading
Recursion Pharmaceuticals is trading at $3.44 (-5.37%), with the decline appearing aligned with broader risk-off trading. - No clear company-specific...
🟢 Recursion Pharmaceuticals is trading 5% up today with no verified direct catalyst
Recursion Pharmaceuticals is trading $3.62 (+5.09%) with no verified direct catalyst identified. - No confirmed company-specific announcement or analyst...
🟢 Recursion Pharmaceuticals is trading 10% up today amid broad biotech-sector strength
Recursion Pharmaceuticals is trading at $3.58, up 10.00%, supported primarily by broad biotech-sector strength rather than a fresh company-specific...